Tarsus Pharmaceuticals (TARS) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-1.17
-0.94
-0.72
-0.49

Details

Expected EPS
-1.08
Actual EPS
-1.17
Surprise EPS
-0.09
Surprise Percent
+8.33%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -1.17 per share for Q2 2023.

0 Comments

Share your thoughts